Open AccessImpact of the 13-valent pneumococcal conjugate vaccine on the incidence of consolidated pneumonia in children younger than 5 years old in Pilar, Buenos Aires: A population-based study
Author(s) -
Ángela Gentile,
Julia Bakir,
Laura Bialorus,
Laura Caruso,
Diego Mirra,
Celina Santander,
Mabel Terluk,
Pablo Zurdo,
Fernando Gentile,
María I Fermndez
Publication year - 2015
Publication title -
archivos argentinos de pediatría
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 19
eISSN - 1668-3501
pISSN - 0325-0075
DOI - 10.5546/aap.2015.eng.502
Subject(s) - medicine , incidence (geometry) , pneumonia , pneumococcal conjugate vaccine , pediatrics , pneumococcal pneumonia , population , streptococcus pneumoniae , environmental health , microbiology and biotechnology , antibiotics , physics , optics , biology
In January 2012, Argentina introduced the 13-valent pneumococcal conjugate vaccine (PCV13) in its immunization schedule for children younger than 2 years old. Coverage in Pilar in 2012 reached>90% for the first two doses and 60% for the third dose.